参考文献/References:
[1] Kho KA,Chen JS,Halvorson LM.Diagnosis,evaluation,and treatment of adenomyosis[J].JAMA,2021,326:177-178.
[2]Chen J,Porter AE,Kho KA.Current and future surgical and interventional management options for adenomyosis[J].Semin Reprod Med,2020,38:157-167.
[3]王世宣,崔鹏飞,张金金.子宫腺肌病三级管理专家共识[J].实用妇产科杂志,2024,40:106-111.
Wang SX,Cui PF,Zhang JJ.Expert Consensus on the Three-level Management of Adenomyosis[J].JPOG,2024,40:106-111.
[4]中国医师协会妇产科医师分会子宫内膜异位症专业委员会.子宫腺肌病诊治中国专家共识[J].中华妇产科杂志,2020,55:376-383.
Endometriosis Professional Committee of Obstetricians and Gynecologists Branch of Chinese Medical Doctor Association[J].Chin J Obstet Gynecol,2020,55:376-383.
[5]郎景和,陈春林,向 阳,等.子宫肌瘤及子宫腺肌病子宫动脉栓塞术治疗专家共识[J].中华妇产科杂志,2018,53:289-293.
Lang JH,Chen CL,Xiang Y,et al.Expert consensus on the treatment of uterine artery embolization of uterine fibroids and adenomyosis[J].Chin J Obstet Gynecol,2018,53:289-293.
[6]郑 睿,曾 丹,万婷婷,等.预测子宫腺肌症动脉栓塞后病灶治疗应答的多因素logistic回归分析[J].影像诊断与介入放射学,2018,27:96-102.
Zheng R,Zeng D,Wan TT,et al.Multivariate logistic return analysis for predicting the treatment response of lesions after adenomyosis arterial embolization[J].Imaging Diagn Interv Radiol,2018,27:96-102.
[7]Liu S,Peng C,Wang Z,et al.Association of normalization of postoperative carbohydrate antigen 125 levels with treatment failure following uterine artery embolization for adenomyosis[J].J Obstet Gynaecol Res,2023,49:2753-2760.
[8]鲁景元,刘 旸,徐文健.子宫动脉栓塞治疗症状性子宫腺肌病中长期疗效[J].中国介入影像与治疗学,2022,19:683-686.
Lu JY,Liu Y,Xu WJ.Medium and long-term efficacy of uterine artery embolization in the treatment of symptomatic adenomyosis[J].Chin J Intervent Imaging Ther,2022,19:683-686.
[9]Guo W,Hu S,Zeng D,et al.The prognostic role of ovarian endometriosis in symptomatic adenomyosis patients underwent uterine artery embolization[J].Ann Palliat Med,2021,10:2577-2583.
[10]Kobayashi H,Matsubara S,Imanaka S.Relationship between magnetic resonance imaging-based classification of adenomyosis and disease severity[J].J Obstet Gynaecol Res,2021,47:2251-2260.
[11]Pausch AM,Fillebock V,Benli M,Witzel I,Hötker AM.MRI of pelvic endometriosis:evaluation of the mr#Enzian classification and the importance of adenomyosis subtypes[J].Abdom Radiol(NY),2024,49:3241-3250.
[12]Zhang M,Bazot M,Tsatoumas M,et al.MRI of adenomyosis:where are we today?[J].Can Assoc Radiol J,2023,74:58-68.
[13]Guo WB,Hu SQ,Wan TT,et al.Preoperative MRI classification may not predict symptom relief after uterine artery embolization in patients with adenomyosis[J].Curr Med Sci,2021,41:1252-1256.
[14]刘 臻,刘笑默.MRI在不同栓塞策略UAE治疗子宫腺肌症术后效果的评价[J].中国临床医学影像杂志,2023,34:741-744.
Liu Z,Liu XM.Evaluation of the postoperative effect of MRI in the treatment of adenomyosis with UAE with different embolization strategies[J].Chin J Clin Med Imaging,2023,34:741-744.
[15]高兴波,丁 锋,吴 明.MRI用于子宫腺肌病患者微球介入治疗后疗效评价的价值[J].临床放射学杂志,2021,40:2371-2378.
Gao XB,Ding F,Wu M.The value of MRI for the evaluation of the efficacy of microsphere intervention in patients with adenomyosis[J].J Clin Radiol,2021,40:2371-2378.
[16]Turtoczki K,Cho H,Dastaran S,et al.Evaluation of junctional zone differential and ratio as possible markers of clinical efficacy in uterine artery embolisation of adenomyosis[J].CVIR Endovasc,2024; 7:55.
[17]王 申,李 红,王 曦,等.影像组学在肝细胞癌TACE中的应用进展[J].介入放射学杂志,2022,31:829-832.
Wang S,Li H,Wang X,et al.Advances in the application of radiomics in TACE of hepatocellular carcinoma[J].J Interv Radiol,2022,31:829-832.
[18]朱帆东,杨 晨,赵振华.影像组学对评估肿瘤微波/射频消融疗效预后的研究进展[J].介入放射学杂志,2024,33:693-696.
Zhu Fd,Yang C,Zhao Zh.Research progress of radiomics on evaluating the efficacy and prognosis of tumor microwave/radiofrequency ablation[J].J Interv Radiol,2024,33:693-696.
[19]Li Z,Zhang J,Song Y,et al.Utilization of radiomics to predict long-term outcome of magnetic resonance-guided focused ultrasound ablation therapy in adenomyosis[J].Eur Radiol,2021,31:392-402.
[20]Liu Z,Liu Z,Wan X,et al.Predicting high-intensity focused ultrasound efficacy in adenomyosis treatment based on magnetic resonance(MR)radiomics and clinical-imaging features[J].Clin Radiol,2025,81:106778.
[21]Jin W,Wang S,Wang T,et al.Multi-machine learning model based on habitat subregions for outcome prediction in adenomyosis treated by uterine artery embolization[J].Acad Radiol,2024,31:4985-4995.
[22]Jin WT,Zhang GF,Wang TP,et al.Nomogram for predicting the long-term outcomes of uterine artery embolization for adenomyosis[J].Eur J Radiol,2022,148:110183.
(收稿日期:2025-02-09)
(本文编辑:谷 珂)
相似文献/References:
[1]谢静燕,王苏征,陈京芳,等.子宫动脉甲氨蝶呤灌注和栓塞治疗子宫腺肌病[J].介入放射学杂志,2008,(07):489.
XIE Jingyan,WANG Suzheng,CHEN Jingfang,et al.Uterine arterial methotrexate infusion and embolization in the treatment of uterine adenomyosis[J].J Intervent Med,2008,(11):489.
[2]艾志刚,杨彦粉,管洁.子宫动脉栓塞治疗子宫腺肌病80例疗效分析[J].介入放射学杂志,2010,(04):325.
AI Zigang,YANG Yanfen,GUAN Jie.Uterine arterial embolization for the treatment of adenomyosis:an analysis of therapeutic results in80cases[J].J Intervent Med,2010,(11):325.
[3]黄明声,朱康顺,李征然,等.子宫动脉栓塞对子宫腺肌病患者卵巢功能的影响[J].介入放射学杂志,2006,(01):14.
HUANG Ming-sheng,ZHU Kang-shun,LI Zheng-ran,et al.Clinical study on ovarian function of patients with adenomyosis after uterine artery embolization [J].J Intervent Med,2006,(11):14.
[4]朱春,杨军,陈向宇,等.子宫腺肌病介入治疗初探[J].介入放射学杂志,2006,(03):183.
ZHU Chun,YANG Jun,CHEN Xiang-yu.Primary study on the interventional therapy for adenomyosis[J].J Intervent Med,2006,(11):183.
[5]陈 毅,谢春明,杨敏玲,等. 子宫动脉栓塞术在剖宫产术后子宫瘢痕妊娠治疗中的应用[J].介入放射学杂志,2012,(05):410.
,,et al. The application of uterine artery embolization for the treatment of uterine scar pregnancy after cesarean section[J].J Intervent Med,2012,(11):410.
[6]宋 杰,王黎洲,李 兴,等. 前置胎盘剖宫产术中行子宫动脉栓塞术对防治产后出血的应用[J].介入放射学杂志,2013,(05):418.
SONG Jie,WANG Li? zhou,LI Xin,et al. Uterine artery embolization performed during cesarean section due to placenta previa: its application in preventing postpartum hemorrhage[J].J Intervent Med,2013,(11):418.
[7]梁 昊,闫 磊,韩新巍,等.髂外动脉造影在瘢痕子宫产后出血子宫动脉栓塞术中应用价值[J].介入放射学杂志,2018,27(05):481.
LIANG Hao,YAN Lei,HAN Xinwei,et al.The application value of external iliac artery angiography in uterine artery embolization for postpartum hemorrhage in delivery women with scarred uterus[J].J Intervent Med,2018,27(11):481.
[8]黄加胜,张慕玲,束晓明,等.预防性子宫动脉栓塞在产科疾病中的应用[J].介入放射学杂志,2013,(12):980.
HUANG Jia? sheng,ZHANG Mu? ling,SHU Xiao? ming,et al. Clinical application of prophylactic uterine artery embolization in obstetrical diseases[J].J Intervent Med,2013,(11):980.
[9]冯志鹏,张建好,韩新巍,等.卵巢动脉栓塞在子宫出血性疾病介入治疗中的意义[J].介入放射学杂志,2019,28(08):778.
FENG Zhipeng,ZHANG Jianhao,HAN Xinwei,et al.The significance of ovarian artery embolization in interventional therapy of uterine hemorrhagic diseases[J].J Intervent Med,2019,28(11):778.
[10]谢璇丞,范宏杰,赵 卫,等.子宫肌瘤介入治疗现状及研究进展[J].介入放射学杂志,2019,28(09):905.
XIE Xuancheng,FAN Hongjie,ZHAO Wei,et al.Interventional treatment of uterine fibroids: its current situation and research progress[J].J Intervent Med,2019,28(11):905.
[11]程曙,王士甲,张国福.子宫动脉栓塞在治疗子宫腺肌病中占有重要地位[J].介入放射学杂志,2010,(12):925.
CHENG Shu,WANG Shi-jia,ZHANG Guo-fu..The significant value of uterine artery embolization in treating adenomyosis[J].J Intervent Med,2010,(11):925.